CXCR5 and COVID-19: This is a very intriguing piece of data, since CXCR5 did not show any statistically significant difference in its expression on B lymphocyte subsets comparing young and old subjects (Bulati et al., 2014), thus it is not expected to be differentially modulated in COVID-19 as a consequence of aging.